The shares of Strides Pharma were trading in green on Wednesday after the company announced that its step down wholly-owned subsidiary, Strides Pharma Global Private Limited (Singapore) received approval from the United States Food and Drug Administration (USFDA) for its Tetracycline Hydrochloride Capsules USP, 250 mg and 500 mg.